4.8 Article

One Stone Two Birds: Zr-Fc Metal-Organic Framework Nanosheet for Synergistic Photothermal and Chemodynamic Cancer Therapy

Journal

ACS APPLIED MATERIALS & INTERFACES
Volume 12, Issue 18, Pages 20321-20330

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/acsami.0c06648

Keywords

photothermal therapy; chemodynamic therapy; cancer therapy; two-dimensional material; metal-organic framework

Funding

  1. National Natural Science Foundations of China [NSFC 21875212, 51632008, 51672247]
  2. China Postdoctoral Science Foundation [2018M643148]
  3. Provincial Key Research Program of Zhejiang Province [2020C04005]
  4. Zhejiang Natural Science Foundation [LD18E02001]
  5. Shenzhen Science and Technology Project [KQJSCX20170727101208249, JCYJ20170412105400428]

Ask authors/readers for more resources

Metal-organic frameworks (MOFs) have been identified as promising materials for the delivery of therapeutics to cure cancer owing to their intrinsic porous structure. However, in a majority of cases, MOFs act as only a delivery cargo for anticancer drugs while little attention has been focused on the utilization of their intriguing physical and chemical properties for potential anticancer purposes. Herein for the first time, an ultrathin (16.4 nm thick) ferrocene-based MOF (Zr-Fc MOF) nanosheet has been synthesized for synergistic photothermal therapy (PTT) and Fenton reaction-based chemodynamic (CDT) therapy to cure cancer without additional drugs. The Zr-Fc MOF nanosheet acts not only as an excellent photothermal agent with a prominent photothermal conversion efficiency of 53% at 808 nm but also as an efficient Fenton catalyst to promote the conversion of H2O2 into hydroxyl radical (center dot OH). As a consequence, an excellent therapeutic performance has been achieved in vitro as well as in vivo through this combinational effect. This work aims to construct an all-in-one MOF nanoplatform for PTT and CDT treatments without incorporating any additional therapeutics, which may launch a new era in the investigation of MOF-based synergistic therapy platforms for cancer therapy.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available